Trial Profile
Pivotal phase IIb study of PYN17 in patients with chronic hepatitis C
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Feb 2016
Price :
$35
*
At a glance
- Drugs PYN 17 (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Phynova
- 16 Feb 2016 New trial record